Human hepatocyte transplantation is gaining acceptance for the treatment of liver diseases. However, the reagents used to isolate hepatocytes from liver tissue are not standardized and show lot-to-lot variability in enzyme activity and endotoxin contamination. For clinical application, highly purified reagents are preferable to crude digest preparations. A purified tissue dissociating enzyme (TDE) preparation (CIzyme TM purified enzymes) was developed based on the enzyme compositions found in a superior lot of collagenase previously used by our group for human hepatocyte isolation. The performance of this enzyme preparation was compared to collagenase type XI on 110 liver cases by assessing hepatocyte yield, viability, and seven other functional assays that included plating efficiency, basal and induced CYP450 activities, phase II conjugation activity, and ammonia metabolism. No statistically significant difference was observed between these TDEs when they were used to isolate hepatocytes from liver resections or organ donor tissue on 54 hepatocyte isolations with type XI enzyme and 56 isolations using CIzyme TM . These results show that a highly purified and defined TDE preparation can be formulated that provides excellent performance with respect to viability, yield, and functional activity of the isolated cells. In addition to reproducible formulation, these purified enzyme products have only 2-3% of the endotoxin of crude enzyme preparations. These results show that purified enzymes such as CIzyme TM will be a safe and effective for the isolation of human hepatocytes for clinical transplants.
INTRODUCTION
product (4, 18) . A critical component that should be addressed early in the standardization process is characterization and formulation of a purified tissue dissoThe inability of orthotopic liver transplantation to meet the increasing demand for treating patients with ciation enzyme (TDE) reagent optimized for human hepatocyte isolation. acute or end stage liver disease indicates a need to develop alternative approaches to treat liver disease.
The present report describes the preparation of a purified TDE mixture that was formulated to replicate the Hepatocyte transplantation has been successfully used to treat chronic and acute liver failure and to correct inhermost useful biochemical characteristics of a specific lot of an enriched TDE product with a proven history of ited metabolic diseases (6, 10, 11, 22, 27, 30, 32, 34, 35) . Translation of this cell therapy procedure from experisuccessful human hepatocyte isolations (Sigma type XI, Lot 044K8638). Class 1 (C1) and class 2 (C2) collagenmental to routine clinical practice requires development of standardized methods to generate a cGMP hepatocyte ase and a neutral protease (thermolysin) have been 1246 GRAMIGNOLI ET AL.
shown to be the active components responsible for sucFive lots of Sigma type XI (Sigma, St. Louis, MO) and six lots of VitaCyte MA were analyzed by the biochemicessful rat hepatocyte isolation (9) . The new formulation described in this report was empirically determined by cal procedures outlined below. The type XI product was reconstituted from the lyophilized powder by mass in reverse engineering to produce an enzyme composition similar to those found in the type XI product. Several water. The insoluble portion of type XI was clarified by centrifugation and the analysis performed on the clarified different formulations using purified components were tested for their ability to achieve similar or superior supernatant. The concentration of purified MA collagenases was determined spectrophotometrically assuming 1 results to type XI collagenase in human hepatocyte isolation before defining a final formulation of collagenase mg of purified collagenase had an A 280 = 1.41. C1 and C2 and a protease from Bacillus polymyxa. An extensive comparison of human hepatocyte yield and
High-Performance Liquid Chromatography (HPLC) function from cells isolated with either the type XI or
Chromatography was performed on a Beckman Systhe final purified enzyme formulation showed that simitem Gold HPLC using a Mono-Q anion exchange collar results were obtained with cells prepared with either umn (5 × 50 mm, GE Healthcare; Piscataway, NJ) with TDE. The primary advantages of using a defined formua Tris-Ca 2+ mobile phase and a NaCl gradient as prelation in this application is consistency of manufacture, viously described (21). Peak assignments of C2, C1 intact , dramatic reduction in contamination with bioactive suband C1 100kDa were made based on internal analysis of stances (e.g., endotoxin), and the ability to further optifractionated purified collagenase. Approximately 1 mg mize enzyme compositions to improve the quality and of the collagenase blends was passed over the Mono-Q yield of hepatocytes. In this study we determined that column with ultraviolet detector monitoring at 280 nm there was no significant difference between the viability with integration performed by 32Karat software. This and function of hepatocytes isolated with either enzyme analysis provides an excellent assessment of the quality preparation when they were used to isolate hepatocytes of collagenase found in any TDE product since the retenfrom liver resections (LR) or organ donor (OD) tissue tion times correlate with the molecular form and specific with 54 hepatocyte isolations (41 LR, 13 OD) and 56 activity of the collagenase enzymes (21). The earliest elutisolations (42 LR and 14 OD) using type XI and CIzying peak is C2 with a retention time of ϳ13-13.5 min. me TM enzymes, respectively. C1 116kDa enzyme eluted next at ϳ19-19.5 min followed by the other two molecular forms of C1 100kDa : C1b and C1c
MATERIALS AND METHODS
eluting at ϳ20-20.5 and ϳ21.5-22 min, respectively.
Tissue Dissociation Enzymes
Assays for Enzyme Activity VitaCyte's CIzyme TM Collagenase MA (MA), hereafter referred to as CIzyme TM , was purified from C. histoThe CDA fluorescence microplate assay procedure is lyticum culture supernatants. The raw material used for described elsewhere (21). Specific activities were calcupurification was obtained after fermentation under lated by dividing the CDA enzyme units (CDA U = 1 anaerobic conditions in media that contained porcine fluorescent unit per min) by the milligram of protein. gelatin and porcine pancreatic enzymes as the only aniThe specific CDA of the different molecular forms idenmal sourced components. A three-column purification tified in the HPLC profile were found to be similar for scheme led to the isolation of three different molecuthe C2 and C1 100kDa forms of collagenase. However, lar forms of collagenase, all active in degrading native C1 116kDa was found to have a specific CDA approxicollagen: intact class 1 (C1 116kDa ), degraded class 1 mately 10-fold higher than the other molecular forms. (C1 100kDa ), and intact class 2 (C2; 114 kDa) (21). C1 116kDa The same assay format as the CDA assay was used to has two collagen binding domains (CBDs) while C1 100kDa assess neutral protease activity (NP U) but 100 µg of and C2 possess single CBDs (20) . The three purified fluorescein isothiocyanate (FITC)-bovine serum albucollagenases were blended by mass to achieve a 60% min was used in place of FITC fibril (5). The Wunsch C1 (comprised of both C1 116kDa and C1 100kDa ): 40% C2 activity of enzyme solutions was measured at 25°C as ratio. The total collagen degrading activity (CDA) of the described previously (42). MA enzyme blend was targeted to match the total CDA measured in 125 mg of the reference lot of Sigma type Assays for Endotoxin XI. Vitacyte's thermolysin and BP protease from B. polymyxa were purified by column chromatography with Endotoxin levels in each enzyme product were quantified using either the Limulus Amebocyte Lysate (LAL) the amount of neutral protease activity used in the hepatocyte isolation procedure being similar to that found in kinetic assay (QCL-1000; Lonza, Walkersville, MD) or the Endosafe-PTS rapid assay (Charles River; Wilmington, the Sigma type XI reference lot.
MA) according to the manufacturers' instructions. Each dependent on the number of catheters and size of tissue (35-240 ml/min in this study). The bag containing the product was tested for interference by measuring the recovery of a known amount of endotoxin spiked into tissue was placed in a circulating water bath at 37°C and the tissue was perfused with HBSS supplemented with each sample dilution. 0.5 mmol/L ethylene glycol tetraacetic acid (EGTA) Hepatocyte Isolation without recirculation. Chelation of calcium by EGTA aids in the dissolution of intercellular junctions between All human tissues were collected with informed consent following ethical and institutional guidelines. The hepatocytes and in the washing of hematopoietic cells. A second, nonrecirculating perfusion with HBSS withtissue dissociation and subsequent hepatocyte isolation procedures used were developed by Seglen and modified out EGTA was performed to flush residual EGTA from the tissue since calcium is essential for TDE activity. as described previously (8, 24, 29, 36, 37) . A total of 110 liver tissues were used in these studies; 83 were derived Finally, tissues were perfused with a third buffer composed of EMEM supplemented with the TDEs and recirfrom patients undergoing scheduled liver resection (LR). Residual tissue not needed for diagnostic purposes was culated as long as needed to complete the digestion. Enzymes from both manufacturers were reconstituted transported to the laboratory from the operating rooms in cold Eagle's minimum essential medium (EMEM)
per manufacturers' recommendations, filtered, and added to the EMEM just prior to perfusion. Collagenase (Lonza) within 30 min of removal. Most of the liver resections were the result of metastatic colon cancer.
type XI (Sigma-Aldrich) was used at a concentration of 250 mg/L and was supplemented with 50 mg/L DNase Organs not used for orthotopic liver transplantation (27) were obtained 3-24 h after cross-clamp and in situ per-(Sigma-Aldrich). CIzyme TM collagenase MA (VitaCyte) concentration was 100 mg/L with 24 mg CIzyme TM BP fusion. Two of the donor livers were from non-heartbeating donors and were reported to have 15 and 40 min Protease (VitaCyte) in 1 L of EMEM immediately before perfusion. of warm ischemia. Seven livers were from donors with extended anoxic periods: three from drug overdose vicIn general, hepatocyte isolations from OD required 1 L of each buffer solution for each lobe, while those from tims, two from drowning, and two additional with cardiac arrests followed by resuscitation. Four cases were LR utilized half this volume. The duration that the tissue was exposed to the different buffers was dependent upon tissues remaining following organ transplantation. Remaining donor livers displayed moderate to severe flow rate of the peristaltic pump, number of catheters, and quality of the tissue; but perfusion of the first two steatosis (35-65% macrosteatosis) or were rejected for transplantation because of anatomical defects such as buffers usually resulted in sufficient rinsing and warming of the tissue within 20-30 min. Perfusion times for calcifications or plaques in the vessels. When whole organs were obtained, they were surgically reduced to the EMEM-TDE solution varied among the tissue specimens and were determined subjectively by continual smaller size for more effective perfusion. The left lateral segment was processed first after anatomical dissection monitoring of the tissue integrity. Perfusion was stopped when the liver tissue beneath the capsule surface was from the right lobe, 2-3 cm from the falciform ligament. If necessary, the right lobe was divided in two parts and visibly digested and separated from the capsule, which normally took about 25-35 min; thus, the total time of processed as separate tissues.
From this point forward, the procedure for hepatocyte perfusion needed for cell isolation ranged from 40 to 65 min. The tissue was then transferred to a sterile plastic isolation was the same for OD and LR tissues. Silicone catheters were inserted into the major portal and/or beaker that contained ice-cold EMEM and gently chopped with sterile scissors to release hepatocytes. The hepatic vessels and the tissue was perfused with Hank's balanced salt solution (HBSS; without calcium, magnecell suspension was filtered through sterile gauze-covered funnels to remove cellular debris and clumps of undisium, and phenol red; Lonza) to determine which vessel(s) provided the most uniform perfusion of the tissue. gested tissue. Hepatocytes were enriched by three consecutive centrifugation steps at 80 × g for 6 min each at After the best vessels were identified, purse string sutures were used to encircle each vessel with its accom-4°C. After three washes in EMEM, hepatocytes were suspended in cold Hepatocyte Maintenance Medium panying catheter and the sutures were drawn tight to prevent the leakage of buffer around the catheter during the (HMM, Lonza). Cell viability was assessed by mixing an aliquot of the final cell suspension with an equal volperfusion. Excess suture material was tied to catheters to further secure them to the liver. Perfusion proceeded ume of 0.4% (w/v) trypan blue in phosphate-buffered saline and counting the number of viable (unstained) and once all remaining major vessels on the cut surfaces were closed with sutures or surgical grade superglue.
dead (blue) hepatocytes with the aid of a hemacytometer. Viabilities are expressed as a percentage of the total The liver tissue was then placed in a sterile plastic bag and connected to a peristaltic pump with flow rate cell number.
Plating Efficiency isolation and in cultured hepatocytes after treatment for 3 days with a specific 1A1/2 inducer (BNF) or vehicle Cells were resuspended in HMM supplemented with control (DMSO). Briefly, cells are incubated for 1 h at insulin (10 −7 M), dexamethasone (10 −7 M), and antibiotics-37°C with 7-ethoxyresorufin solution (20 µM, Sigmaantimycotics (Antibiotic-Antimycotic Solution; BioGemini) Aldrich) and salicylamide (1.5 mM, Sigma-Aldrich). containing 5% bovine calf serum (Sigma-Aldrich). One
Salicylamide was added to prevent conjugation of the milliliter of the cell suspension (7.5 × 10 5 viable cells/ fluorescent product. After 1-h incubation, the media was ml) was seeded in each well of a six-well culture plate collected, clarified by centrifugation, and frozen. One precoated with type I rat collagen (0.03 mg/ml concenhundred microliter of each sample, analyzed in triplitration). Cells were cultured at 37°C in a humidified cate, was added to a 96-well white plate and analyzed atmosphere of 5% CO 2 /95% air. Two hours after plating, on a fluorescent spectrometer (Synergy HT, BioTek media from half the wells was collected, centrifuged to Instruments, Inc., Winooski, VT) equipped with Gen5 a pellet (200 × g, 5 min), and stored frozen. Media from software at an excitation wavelength of 535 nm and an the remaining wells was discarded and all wells were emission wavelength of 581 nm. Resorufin concentrareplaced with HMM without serum. After 10-18 h, tion was quantified by interpolating the A 581 values for three wells were washed extensively with PBS to disthe unknowns from a standard curve of resorufin card unattached hepatocytes and the remaining three (Sigma-Aldrich) prepared in HMM [resorufin (µg/ml) = wells were not. Cells were scraped and collected and 617844 * A 581 + 171.23; R 2 = 0.9996]. Following samplating efficiency (PE) was determined by measuring the pling period, cells were harvested in phosphate buffer protein content. The cell pellets derived from the three (0.1 M, pH 7.4) and stored at −20°C until protein connonwashed wells were combined with their correspondtent was determined. Results are expressed as picomoles ing 2-h pellet. Protein content was determined with the of product formed/min normalized to 1 million viable Bio-Rad Protein Assay kit (Bio-Rad, Cat. No. 500-cells (suspension cultures) or to total protein content 0006). Plating efficiency was defined as the ratio of total (adherent cultures). protein content in wells after washing (attached cellular protein) to that of nonwashed wells (total cellular proTestosterone Metabolism tein) and is expressed as a percentage.
Testosterone 6β-hydroxylase activity catalyzed by Drug Metabolism Studies CYP3A4 was determined directly both in cell suspensions and in intact cultured hepatocytes, as described Each metabolite was measured in fresh 1-ml cell suspreviously (17) . Briefly, cells were exposed to testosterpensions immediately after digestion and, when possible one (250 µM) for 60 min at 37°C. The media was col-(n = 46), in adherent cultures after 3 days of exposure lected, centrifuged to remove cells and fragments, and to specific prototypical inducers. To evaluate the longstored at −20°C until analyzed by HPLC. Metabolite term activity, cells were plated in collagen-treated 12-was identified by comparing retention times with 6β-well plates with HMM and the medium was changed hydroxytestosterone standard prepared in HMM. Results daily for 2 days to remove dead cells and to let the cytoare expressed as picomoles of product/min and normalchrome p450 (CYP450) gene expression decrease to ized to 1 million viable cells (suspension cultures) or to basal levels. Cells were then incubated for an additional the protein content (adherent cultures). 72 h in the presence of specific inducers [10 µM Rifampicin (rif) and/or 1 µM phenobarbital (PB) for cytoResorufin Assay chrome P450, family 3, subfamily A, polypeptide 4
Phase II activity was determined by the metabolism (CYP3A4); 25 µM β-naphthoflavone (BNF) for of the fluorescent compound resorufin after incubation CYP1A1/2; and 0.1% dimethylsulfoxide (DMSO) as for 30 min at 37°C and measurement of the decrease in vehicle control (all from Sigma-Aldrich) with replenishfluorescent signal. A 50 ng/ml solution of resorufin was ment every 24 h as previously described (17)]. Results added to hepatocytes, and one well was immediately are expressed as product mol/min and normalized to a centrifuged and the supernatant retained as "time 0" and million of viable cells for experiments conducted with then stored frozen. Subsequent time point samples were fresh cells in suspension cultures or per milligram total centrifuged to remove cells and debris and then stored cellular protein for cultured cells.
frozen until analyzed with the same conditions described
7-Ethoxyresorufin-O-Deethylase (EROD)
for the EROD assay. Resorufin metabolism was quantified by comparing the fluorescent signal after 30 min to Cytochrome P450-1A1/2 phase I activity was assessed by the conversion of 7-ethoxyresorufin to resorufin as the time 0 value. All the results are expressed as percentage of resorufin metabolized or as picomoles of product described previously (40). EROD activity was measured in 1 million viable cells in suspension immediately after formed/min and normalized to 1 million viable cells (suspension cultures) or to total protein content (adherhepatocyte isolation. In this and in all subsequent purified blend formulations described below, a 60:40 ent cultures).
(C1 116kDa + C1 100kDa ):C2 enzyme mixture was prepared Ammonia Metabolism and the dose used for hepatocyte isolation was adjusted to match the enzyme activity found in Lot 044K8638. Cells isolated with enzymes from both vendors were evaluated for ammonia metabolism by direct in vitro
The initial purified blend (blend A) was based upon matching the total Wunsch and neutral protease activity colorimetric determination of ammonia (26). Hepatocytes were treated with 1 mM ammonium chloride (NH 4 Cl) for (as assessed by the azocasein assay) (28) Reanalysis of the enzymatic activity for Lot 044K8638 using other assays of collagenase and neutral protease showing mean ± SEM. Data presented as mean ± SEM were compared by unpaired t-test. A value of p < 0.05 activities led to a second formulation of a purified blend (blend B) that matched the reference lot for CDA rather was chosen as the minimum level of significance. All data were analyzed by GraphPad Prism software (verthan Wunsch activity as a measure of collagenase activity and FITC-BSA rather than azocasein as a measure sion 5.03, GraphPad Software Inc.). Although data from organ donors and liver resections are presented in the of neutral protease activity. To ensure the closest match of specific CDA to the reference material, blend B consame figures or tables, statistical analysis was only conducted between the same tissue sources for each enzyme tained both molecular forms of C1 (C1 116kDa and C1 100kDa ) and C2 with the total CDA U targeted to be the same as preparation. Data from organ donors were not compared to those obtained from liver resections.
the reference lot (ϳ5.0 million total CDA U/L solution). BP protease was used in place of thermolysin since it RESULTS had a similar specificity as thermolysin but a turnover number 2.5× lower when the specific activities of the One lot of Sigma type XI collagenase (044K8638) was found to be exceptional for its ability to provide purified enzymes were assayed using FITC-BSA as substrate (5). The results from human hepatocyte isolations human hepatocytes with excellent viability and plating efficiency following isolation based on the experience using blend B showed superior results when compared to blend A: higher cell viability and uniform dissociation with over 200 hepatocyte isolations, so we attempted to recreate the enzyme composition found in that particular of tissue. The time for completion of the tissue digestion was dependent on the concentration of neutral protease preparation. The HPLC chromatogram and enzyme activity analysis of this particular material (Fig. 1, top) used in the digest with higher amounts of enzyme shortening the digestion time. After optimization of the BP and two additional lots of the Sigma type XI product (Fig. 1, middle and bottom) revealed many contaminatprotease activity, further adjustments were made to the collagenase activities, resulting in an optimized tissue ing components, as well as highly variable ratios of the collagenase molecular forms. The superior lot had dissociation enzyme formulation containing 2.5 million CDA U and 24 mg of BP protease/L of tissue dissociaunique characteristics: a relatively high specific CDA and neutral protease activity. After the supply of this tion enzyme solution.
The HPLC chromatograms for the three different lots lot was exhausted, Lot 118K8608 (Fig. 1, bottom) was purchased as a replacement, but it was found to provide of CIzyme TM are presented in Figure 2 . These results demonstrate the purity of the individual components and lower hepatocyte viability and plating efficiency when compared to isolations performed with Lot 044K8638 consistency of product manufacture. The apparent difference in the chromatogram shown in Figure 2 (top) is (data not shown).
Type XI lot 044K8638 served as the reference matea consequence of the inclusion of C1c in the formulation which, like C1b, is an active enzyme with a single CBD. rial to define a purified enzyme blend for use in human While there is variability in the C1 molecular forms between lots, these differences were intentional at the time of manufacture to achieve a more consistent specific CDA. The reduction in contaminating proteins results in lots of collagenase blends that are better characterized and are more consistent.
Both of these molecular forms are effective in degrading Tissue was randomly processed with either Sigma collagenase type XI (13 ODs and 41 LRs) or the CIzyme TM native collagen and have similar specific CDA that are lower than that of intact C1. The presence of C1c in enzymes (14 ODs and 42 LRs). Table 2 summarizes patient demographics and isolation results including this formulation was intentional and does not represent a contaminating or an ineffective enzyme.
hepatocyte yield and cell viability. As shown in Table 2 , the demographics of the two Table 1 summarizes the lot-to-lot consistency of Sigma type XI collagenase, CIzyme TM , and Vitacyte BP study groups were equivalent in terms of age, gender, and weight of tissue processed and the source of tissue protease as assessed by enzyme specific activities and endotoxin contamination. The specific CDA and neutral (OD vs. LR). Figure 3 presents data on viability, cell yield, and plating efficiency on hepatocytes isolated protease activities of these six lots of CIzyme TM and four lots of BP protease were less variable than similar with both enzyme sources. Figure 3a , c, and e presents data from both LR and OD for each enzyme source, enzyme activities measured in the various lots of the type XI product. There was also a substantial difference while in Figure 3b, (Fig. 3a, b) . Yield of viable hepatocytes from LR did In this study, hepatocytes were successfully isolated from 110 of 115 total tissues acquired. Five cases were not differ between isolations performed with Sigma type XI and CIzyme TM (10.6 ± 7.8 and 8.2 ± 5.7 million cells/ deleted from the study prior to data analysis for poor initial viability: four ODs for a prolonged cold ischemia, g tissue, respectively) ( Fig. 3c, d ). However, in OD the yield of viable hepatocytes appeared lower in isolations over 36 h, and one LR from a colangiocarcinoma with biliary obstruction and cholestasis. Data from the performed with CIzyme TM relative to those performed with Sigma type XI (4.5 ± 2.8 and 7.0 ± 5.5 million remaining 110 cases were used and the results presented here.
hepatocytes/g tissue, respectively); however, the difference was not statistically significant (Fig. 3b) . These viability measurements and yields are in line with previ- one or more nuclei (Fig. 4) . ity was similar between cells isolated with each enzyme blend (1.9 ± 0.6 vs. 1.3 ± 0.6 pmol/min/million viable sourced from OD or LR tissue for either enzyme combination (Fig. 5d) . cells for the Sigma and CIzyme TM , respectively) (Fig.  5a ). The tissue source had no impact on 1A1/2 metaboAdditional studies investigated the metabolic activity of the cells in longer term cultures (5 days) and also lism in freshly isolated hepatocytes: OD-sourced hepatocytes had comparable 1A1/2 activities whether the investigated whether the induction of specific CYP enzyme was affected by the source of enzyme used for isolation was performed with CIzyme TM or Sigma type XI (1.6 ± 1.0 and 0.7 ± 0.3 pmol/min/million cells, cell isolation. Those results are presented in Figure 6 . In normal hepatocytes, CYP1A1/2 activity can be induced respectively) (Fig. 5a) . Similarly, hepatocytes isolated from LR tissue converted 2.4 ± 0.7 pmol/min/million by prior exposure to prototypical inducers such as BNF; therefore, we examined the induction of CYP1A in culcells when isolated with Sigma type XI collagenase versus 0.8 ± 0.2 pmol/min/million cells when CIzyme TM tured cells. A 3-day exposure of cells to BNF resulted in a robust induction in CYP1A1/2-mediated EROD was used for the isolation (Fig. 5a) .
Testosterone metabolism by CYP3A4 measured activity relative to noninduced controls in hepatocytes isolated from OD and LR (Fig. 6a ). Basal and induced immediately after isolation was similar between hepatocytes isolated with either Sigma type XI or CIzyme TM CYP1A1/2 activities did not differ between hepatocytes isolated with the enzymes from the two vendors (Sigma (0.2 ± 0.0 and 0.3 ± 0.2 nmol/min/million cells, respectively) (Fig. 5b) . If the organ subgroups are analyzed type XI 21.4 ± 4.9 pmol/min/mg vs. CIzyme TM 20.5 ± 2.6 pmol/min/mg) nor were differences between ODseparately, testosterone metabolism was not statistically different between the enzyme sources for LR (0.2 ± 0.1 and LR-derived hepatocytes detected for either enzyme preparation (Fig. 6a) . nmol/min/million of hepatocytes). In the OD group the CIzyme TM isolated cells showed a higher but nonsignifiIn cultured cells induced with Rif or PB for 3 days, both enzyme preparations showed an increase in metabcant ability to hydroxylate testosterone when compared to the type XI group (0.5 ± 0.6 and 0.1 ± 0.2 nmol/min/ olism of at least threefold compared to controls. The increase is most pronounced, and statistically signifimillion of viable hepatocytes, respectively) (Fig. 5b) .
Conjugation of resorufin in freshly isolated cells was cant, if compared for LR-derived hepatocytes isolated with either vendor when treated with PB for 3 days comparable between LR-derived hepatocytes isolated with enzymes from either vendor (3.45 ± 0.83 and 3.15 ± (0.67 ± 0.18 and 2.14 ± 0.36 nmol/min/mg, for type XI and CIzyme TM , respectively; p = 0.026) (Fig. 6b) . 0.97 pmol/min/million viable hepatocytes, respectively) (Fig. 5c) . Similarly, hepatocytes isolated from OD with Although each individual human case responded with an increase in CYP3A4 activity when the cells were CIzyme TM had phase II activities comparable to those isolated from OD with Sigma type XI collagenase (5.43 ± exposed to Rif, because of the wide range of response to Rif induction between cases, when all of the samples 0.62 vs. 2.92 ± 1.02 pmol/min/million hepatocytes, respectively) (Fig. 5c) .
were analyzed together the difference was not statistically significant (0.78 ± 0.33 vs 2.30 ± 0.38 nmol/min/ Ammonia metabolism was analyzed in 29 preparations of cells (10 with type XI collagenase and 19 with mg, respectively, for type XI-and CIzyme TM -treated cells; p = 0.13) (Fig. 6b) . In hepatocytes isolated from CIzyme TM ). Average rates of ammonia conversion measured immediately after isolation were 43.9 ± 8.6 and OD, the 3A4-mediated activity was similar when induced by either PB or Rif. The induced activity by PB 39.0 ± 12.8 pmol/min/million viable cells for hepatocytes isolated with Sigma type XI and CIzyme TM , in OD-derived hepatocytes appeared lower, but was not significantly lower in cells isolated with type XI enzyme respectively, with no differences between hepatocytes compared to CIzyme TM (1.62 ± 0.79 and 3.14 ± 1.35 DISCUSSION nmol/min/mg, respectively) (Fig. 6b) . No difference was observed between the two enzyme preparations in cells Little has changed in the quality of TDEs used in human hepatocyte isolation since Seglen reported his from OD induced by Rif (2.85 ± 1.45 and 3.21 ± 1.29 nmol/min/mg, respectively, in type XI and CIzyme TM improvements to the Berry and Friend isolation procedure (3,29). Typically, the TDEs used for these isolation groups) (Fig. 6b) .
Hepatocytes isolated from LR tissue and subseprocedures are minimally purified biochemical products that are derived from C. histolyticum culture supernaquently cultured for 5-6 days showed similar rates of resorufin conjugation (6.91 ± 2.25 and 5.67 ± 1. 24 tants that are grown in culture media that usually contains animal protein (i.e., protease peptone) since early pmol/min/mg protein for Sigma type XI and CIzyme TM , respectively) (Fig. 6c) . Resorufin metabolism was also studies showed that rich media was required for expression of collagenase enzymes (2). This raises a concern similar between OD-derived hepatocytes isolated with CIzyme TM and Sigma type XI collagenase (5.86 ± 1.16 of transmission of transmittable spongiform encephalopathy (TSE) since cells prepared with these enzymes are and 6.80 ± 3.50 pmol/min/mg protein) (Fig. 6c) . Resorufin conjugation activity of hepatocytes isolated from used in cell transplantation procedures. In 2007, the NIH suspended the use of Liberase HI in the Clinical Islet one OD with the Sigma enzyme was omitted from the mean presented in Figure 6c as this donor had a history Transplantation Consortium clinical trial because bovine brain-heart infusion in the C. histolyticum culture media of high alcohol consumption and exorbitantly high phase II activity (29 pmol/min/mg) relative to all others used to generate the crude collagenase posed a potential risk for TSE (16, 25) . However, subsequent analysis examined. Inclusion of this subject in the statistical analysis did not affect the statistical outcome but would showed that the risk of transmission was minimal (≤1 in 10 million), assuming that the tissue was obtained from skew the mean for this group to 14.07 ± 7.54 pmol/ min/mg protein.
a clean US herd (25). The current suppliers of purified TDEs have further minimized this risk by using culture In hepatocytes isolated from LR and cultured as adherent monolayers, in vitro, ammonia metabolism was media containing bovine proteins that meet European directives for minimizing TSE (Serva); or porcine pro-102 ± 16.0 and 74 ± 21 pmol/min/mg in hepatocytes isolated with CIzyme TM and Sigma type XI, respectively teins (VitaCyte) since no evidence exists for naturally occurring TSE in pigs. Nor has TSE been transmitted (Fig. 6d) . OD-derived hepatocytes displayed highly variable rates of ammonia metabolism with no significant when pigs were fed a dose of neural tissue infected with mad cow disease at a dose 50,000-fold higher than differences between hepatocytes isolated with the two enzyme sources (112.8 ± 47.8 and 27.8 ± 15.9 pmol/ would normally be expected in a contaminated tissue (39) . Finally, other suppliers use media free of any mammin/mg, respectively, for CIzyme TM and Sigma type XI) (Fig. 6d) .
malian proteins in preparing crude collagenase (Roche). However, these sources still contain considerable have been shown to be the key enzymes responsible for releasing cells from mammalian tissue during an enzymeamounts of endotoxin. The commonly used commercial collagenase products can be subdivided into two grades: mediated tissue dissociation procedure (12, 13, 15, 33, 38, 41) . Two reports in the literature confirm this observacrude or enriched collagenase. These products differ by the degree of purification, which is reflected by the spetion for rodent hepatocyte isolation. Hatton and colleagues passed crude collagenase over several different cific activity of the collagenase enzymes and by the amount of pigment in the final product. The high lot-toresins and combined different chromatographic fractions to show that collagenase and neutral protease were lot variability in enzyme activity and endotoxin contamination in both classes of products directly reflects the required for effective rat hepatocyte isolation (12) . Research studies performed during the development of enzyme activities found in the culture supernatants. This variability led many manufacturers to establish "lot the Liberase Purified Enzyme Blend products showed that enzyme mixtures that contained a 60:40 mixture of qualification" programs that allowed customers to pretest small portions from a larger lot of product in their C1:C2 and thermolysin were as effective as a "good lot" of crude collagenase in isolating rat hepatocytes (9) . specific application prior to purchase.
Collagenase from C. histolyticum and a neutral metalThere have been reports of using different Liberase purified TDEs for rodent (19, 43) , porcine (7), and human loprotease from one of several different bacterial species hepatocyte isolation (14, 23, 24, 31) , but no systematic 60:40 C1:C2 collagenase and thermolysin (blend A).
Comparisons of viability and viable cell yield per gram study has been performed to optimize the enzyme composition for isolation of human hepatocytes.
of tissue from cells isolated using blend A or type XI collagenase showed that use of either enzyme gave simiThis report used a novel, "reverse engineering" approach to define a purified TDE composition for lar viable cell yields per gram of tissue but the cell viability was significantly lower when blend A was used in human hepatocyte isolation. The enzyme activities used in this formulation were based on the enzyme activities the isolation procedure. This led to reassessment of the type XI activities using a different set of enzymatic found in an exceptional lot of Sigma type XI that was routinely used by our laboratory on over 200 human assays. Consequently, a second enzyme formulation (blend B) that contained CDA activity comparable to hepatocyte isolations.
During the course of this development, several forthat of the reference type XI and used B. polymyxa neutral protease in place of thermolysin was evaluated. Durmulations were assessed for their effectiveness to isolate human hepatocytes. The initial formulation contained a ing this set of experiments, the amount of neutral protease used in the isolation procedure was shown to turn could lead to the release of cytokines that may influence hepatocyte engraftment or activate resident have a direct effect on the rate of tissue digestion. After an optimal dose of neutral protease was defined, the stellate cells. The heterogeneity of human liver tissue cannot be total CDA was reduced in half (similar amount used in blend A) with no adverse affect of the cell yield or viacontrolled, but the conditions and reagents for hepatocyte isolation can be standardized, even continually bility. The defined enzyme formulations contained 2.5-5.0 million CDA U and 24 mg of BP protease/L of improved by careful attention to each step of the isolation process. Results presented here demonstrate that a enzyme solution. Since these formulations did not affect hepatocyte yield or viability, these data were pooled for critical part of the isolation process, a digestive enzyme preparation, can be produced that is highly effective for statistical comparison with the type XI enzyme.
In the current study, the performance of a purified the isolation of viable and functional human hepatocytes. Additionally, since the TDE is produced from enzyme blend in human hepatocyte isolation procedures was matched to that of an exceptional lot of enriched highly purified components, one is able to attain consistent lot-to-lot characteristics with respect to enzyme collagenase. Performance characteristics of the enzymes in the digestion itself (cell yield, viability, and digestion activity while minimizing unwanted activities and contamination with byproducts such as endotoxin. Based on times) and functional characteristics (plating efficiency, basal and induced CYP450 activities, phase II conjugapart to data presented here, the TDE described has been included on an IND approved by the United States Food tion activity, ammonia metabolism) of the hepatocytes immediately following isolation and after several days and Drug Administration for the isolation and transplantation of human hepatocytes so the data will soon be in culture did not differ. Moreover, CIzyme TM and type XI enzymes were both effective in isolating hepatocytes available on the clinical effectiveness of hepatocytes produced with this product. from tissue sourced from LR and OD.
The primary advantage of using defined enzyme
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